Target intelligence / Profile preview

Aconitase 2, mitochondrial pseudogene

Molecular classification: Other (Pseudogene)

Overview

Aconitase 2, mitochondrial pseudogene (ENSG00000228367/LOC100996384) is a nonfunctional genomic sequence related to the protein-coding gene ACO2, which encodes mitochondrial aconitase, an enzyme involved in the tricarboxylic acid (TCA) cycle. Pseudogenes such as LOC100996384 do not produce active proteins and are generally considered evolutionary remnants without direct physiological or pharmacological relevance. This entry should not be treated as a therapeutic target or included in drug discovery databases except for annotation purposes[1].

Other names: LOC100996384ENSG00000228367

Mechanism of action

None. Drugs do not target pseudogenes, as they do not produce active proteins.

Biological functions

Other

Disease associations

Other

Beyond the preview

Go deeper on Aconitase 2, mitochondrial pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aconitase 2, mitochondrial pseudogene.

Explore the full profile